COVID-19 Neurologic Complications: Difference between revisions
Jump to navigation
Jump to search
(Undo revision 1617152 by Fahimeh Shojaei (talk)) Tag: Undo |
No edit summary |
||
| Line 15: | Line 15: | ||
*'''Pathophysiology''' | *'''Pathophysiology''' | ||
**The exact pathogenesis of headache in COVID 19 patients is not fully understood. | **The exact pathogenesis of headache in COVID 19 patients is not fully understood. | ||
**It is thought that headache is the result of:<ref name=" | **It is thought that headache is the result of: | ||
*** | ***Cytokine release <ref name="BaigKhaleeq2020">{{cite journal|last1=Baig|first1=Abdul Mannan|last2=Khaleeq|first2=Areeba|last3=Ali|first3=Usman|last4=Syeda|first4=Hira|title=Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms|journal=ACS Chemical Neuroscience|volume=11|issue=7|year=2020|pages=995–998|issn=1948-7193|doi=10.1021/acschemneuro.0c00122}}</ref> | ||
****There is higher concentration on IL-6 and INF-gamma in patients infected with SARS/ CoV2. | |||
****Cytokines can disrupt blood brain barrier and cause tissue injury and cerebral edema. | |||
**** | |||
**** | |||
***Direct invasion | ***Direct invasion | ||
***Metabolic disturbances | ***Metabolic disturbances | ||
| Line 138: | Line 142: | ||
<br /> | <br /> | ||
==References== | ==References== | ||
<references /> | |||
Revision as of 21:06, 24 June 2020
To go to the COVID-19 project topics list, click here.
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19 Neurologic Complications On the Web |
|
American Roentgen Ray Society Images of COVID-19 Neurologic Complications |
|
Risk calculators and risk factors for COVID-19 Neurologic Complications |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D., Rinky Agnes Botleroo, M.B.B.S., Wajeeha Aiman, M.D.[2]
Overview
Pathophysiology of the Complications in the Nervous System
Mechanism of targetting the Nervous System
Complications in the Central Nervous System
Headache
- Pathophysiology
- The exact pathogenesis of headache in COVID 19 patients is not fully understood.
- It is thought that headache is the result of:
- Cytokine release [1]
- There is higher concentration on IL-6 and INF-gamma in patients infected with SARS/ CoV2.
- Cytokines can disrupt blood brain barrier and cause tissue injury and cerebral edema.
- Direct invasion
- Metabolic disturbances
- Inflammation
- Dehydration
- Hypoxia
- Cytokine release [1]
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Cerebrovascular Accident/Stroke
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Acute Encephalitis
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Viral Meningitis
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Epileptic Seizures
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Encephalopathy
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Complications in the Peripheral Nervous system
Guillain-Barre syndrome
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Anosmia
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Acute Myelitis
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Miller Fischer Sydrome
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Polyneuritis Cranialis
- Pathophysiology
- Natural history
- Sign and symptoms
- Diagnosis
- Treatment
Complications due to medication interaction
1. Statin induced myotoxicity
- Myalgia, myopathies, rhabdomyolysis
2. 2nd and 3rd degree atrioventricular block
- Lopinavir/ Ritonavir (Kaltera) (400 mg/100 mg)
3. Prolong QTc interval
- Chloroquine/Hydroxychloroquine
4. Myelotoxicity
- Ribavirin
5. Prolonged PR interval
- Atazanavir
6. Myelosuppression
7.
References
- ↑ Baig, Abdul Mannan; Khaleeq, Areeba; Ali, Usman; Syeda, Hira (2020). "Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms". ACS Chemical Neuroscience. 11 (7): 995–998. doi:10.1021/acschemneuro.0c00122. ISSN 1948-7193.